On Monday, Prothena Corporation plc (NASDAQ: PRTA) opened lower -4.45% from the last session, before settling in for the closing price of $8.77. Price fluctuations for PRTA have ranged from $4.32 to $22.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -3.15% over the past five years. Company’s average yearly earnings per share was noted -108.75% at the time writing. With a float of $43.46 million, this company’s outstanding shares have now reached $53.83 million.
Let’s look at the performance matrix of the company that is accounted for 163 employees.
Prothena Corporation plc (PRTA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Prothena Corporation plc is 19.26%, while institutional ownership is 78.31%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -1.1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.18) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -108.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.12% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Check out the current performance indicators for Prothena Corporation plc (PRTA). In the past quarter, the stock posted a quick ratio of 5.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 43.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.63, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Prothena Corporation plc (NASDAQ: PRTA) saw its 5-day average volume 0.84 million, a negative change from its year-to-date volume of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 77.77%.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 51.59%, which indicates a significant decrease from 65.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was lower than the 0.48 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.86, while its 200-day Moving Average is $10.90. Nevertheless, the first resistance level for the watch stands at $8.66 in the near term. At $8.95, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.10. If the price goes on to break the first support level at $8.22, it is likely to go to the next support level at $8.07. Assuming the price breaks the second support level, the third support level stands at $7.78.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
There are currently 53,830K shares outstanding in the company with a market cap of 451.10 million. Presently, the company’s annual sales total 135,160 K according to its annual income of -122,310 K. Last quarter, the company’s sales amounted to 4,420 K and its income totaled -125,770 K.
